Values of BMI, AST, ALT, FBG, TG, SBP, DBP and CRP, and frequencies of hypertension and diabetes were significantly higher in the NAFLD cohort (Table 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.